MicroStrategy Incorporated - Class A Common Stock (MSTR)
387.11
-4.07 (-1.04%)
NASDAQ · Last Trade: Jun 11th, 6:33 PM EDT
Detailed Quote
Previous Close
391.18
Open
391.23
Bid
384.20
Ask
385.18
Day's Range
380.50 - 392.77
52 Week Range
102.40 - 543.00
Volume
6,777,497
Market Cap
6.23B
PE Ratio (TTM)
-14.18
EPS (TTM)
-27.3
Dividend & Yield
N/A (N/A)
1 Month Average Volume
12,460,976
Chart
About MicroStrategy Incorporated - Class A Common Stock (MSTR)
MicroStrategy is a business intelligence and analytics firm that specializes in providing software solutions designed to help organizations make informed decisions based on their data. The company develops and offers a suite of enterprise analytics tools that enable users to visualize, analyze, and interpret large volumes of data. Additionally, MicroStrategy has become notable for its significant investments in Bitcoin, employing its business infrastructure to advocate for cryptocurrency adoption while incorporating blockchain technology into its product offerings. Through its innovative approach, MicroStrategy aims to empower companies with actionable insights and accelerate their digital transformation efforts. Read More
Apple Inc. (NASDAQ:AAPL) is under scrutiny as CNBC's “Mad Money” host Jim Cramer declared that the tech giant's stock buyback program "is not working right now."
AppLovin's S&P 500 exclusion just hit the stock hard. However, analysts at Morgan Stanley remain bullish, announcing a price target increase on the same day.
As Michael Saylor‘s Strategy Inc. (NASDAQ:MSTR) added more Bitcoin (CRYPTO: BTC) and issued a statement announcing an additional $1 billion capital raise, this analyst asked if the BTC Treasury compan
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) and certain officers. The class action, filed in the United States District Court for the Eastern District of Virginia, and docketed under 25-cv-00861, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Strategy securities between April 30, 2024 and April 4, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
U.S. stocks experienced a mixed session today, with the Dow Jones Industrial Average unchanged at 42,761.76 and the S&P 500 moving nearly 0.1% higher at 6,005.88. The Nasdaq rose 0.3% to 19,591.24 on Monday. These are the top stocks that gained the attention of retail traders and investors throughout the day:
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UroGen Pharma Ltd. (NASDAQ:URGN), Strategy Incorporated (NASDAQ:MSTR), and Organon & Co. (NYSE:OGN). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
RADNOR, PA - June 8, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against MicroStrategy Incorporated d/b/a Strategy (“Strategy”) ( NASDAQ: MSTR ) on behalf of those who purchased or otherwise acquired Strategy securities between April 30, 2024, and April 4, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is July 15, 2025.
According to several experts in the sector, Bitcoin ETFs and cryptocurrency-related ETFs have made significant progress since launching in January 2024 and setting inflow records.
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) and certain officers. The class action, filed in the United States District Court for the Eastern District of Virginia, and docketed under 25-cv-00861, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Strategy securities between April 30, 2024 and April 4, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Strategy™ (Nasdaq: MSTR/STRK/STRF) today announced the pricing of its initial public offering on June 5, 2025 of 11,764,700 shares of 10.00% Series A Perpetual Stride Preferred Stock (the “STRD Stock”), at a public offering price of $85.00 per share. The issuance and sale of the STRD Stock are scheduled to settle on June 10, 2025, subject to customary closing conditions.
